Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 42, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s13046-023-02802-1
Keywords
Phosphoflow cytometry; Signaling; PBMC; Clinical response; Solid tumors
Categories
Ask authors/readers for more resources
Tumor biopsy is often difficult to obtain in patients with solid tumors. Investigation of the peripheral immune system allows for in-depth analysis of patient immune response during treatment. Phosphoflow cytometry is a method to detect phosphorylated proteins in single cells and can be used to determine signaling pathway responsiveness in specific immune subsets. This review summarizes the application of phosphoflow cytometry in cancer immunology, including the study of immune cells, tumor microenvironment, drug effects, and prediction of treatment response and outcome. It demonstrates the potential of phosphoflow cytometry in exploring mechanisms of immunotherapy response or resistance and improving cancer patient outcome.
Tumor biopsy is often not available or difficult to obtain in patients with solid tumors. Investigation of the peripheral immune system allows for in-depth and dynamic profiling of patient immune response prior to and over the course of treatment and disease. Phosphoflow cytometry is a flow cytometry. based method to detect levels of phosphorylated proteins in single cells. This method can be applied to peripheral immune cells to determine responsiveness of signaling pathways in specific immune subsets to cytokine stimulation, improving on simply defining numbers of populations of cells based on cell surface markers. Here, we review studies using phosphoflow cytometry to (a) investigate signaling pathways in cancer patients ' peripheral immune cells compared with healthy donors, (b) compare immune cell function in peripheral immune cells with the tumor microenvironment, (c) determine the effects of agents on the immune system, and (d) predict cancer patient response to treatment and outcome. In addition, we explore the use and potential of phosphoflow cytometry in preclinical cancer models. We believe this review is the first to provide a comprehensive summary of how phosphoflow cytometry can be applied in the field of cancer immunology, and demonstrates that this approach holds promise in exploring the mechanisms of response or resistance to immunotherapy both prior to and during the course of treatment. Additionally, it can help identify potential therapeutic avenues that can restore normal immune cell function and improve cancer patient outcome.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available